Scilex Holding Company
Research Scilex Holding Company (SCLX) on Bullrun: market cap USD 39.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSCLX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-General
- CurrencyUSD
- Market capUSD 39.75M
- Financial periodQ1 2026
- RevenueUSD 8.61M
- Net income-USD 43.27M
- Free cash flow-USD 6.93M
- Gross margin234.5%
Valuation Snapshot
latest market cap is USD 39.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 30.25M | -USD 374.05M | USD 3.68M | 415.8% | -36.48 | USD 4.96M | USD 83.26M | -USD 207.78M |
| FY2024 | USD 56.59M | -USD 72.81M | USD 19.35M | 295.8% | -8.05 | USD 3.27M | USD 34.88M | -USD 192.64M |
| FY2023 | USD 46.74M | -USD 114.33M | -USD 20.74M | 66.5% | -1.28 | USD 3.92M | USD 108.43M | -USD 172.94M |
| FY2022 | USD 38.03M | -USD 23.36M | -USD 21.27M | 71.6% | -0.17 | USD 2.18M | USD 0 | USD 36.24M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 39.75M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 85.80M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 78.06M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 199.58M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 563.98M | n/a | n/a | n/a |
| 2021 | 2021-09-29 | n/a | 157.7 | n/a | n/a |
About Scilex Holding Company
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Scilex Holding Company's market cap?
Scilex Holding Company's market capitalization is USD 39.75M.
What does Scilex Holding Company do?
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.